We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CEPI Grants Funding to INOVIO for Phase I/II Trial of COVID-19 Vaccine

Product News   Apr 16, 2020 | Original story from INOVIO

 
CEPI Grants Funding to INOVIO for Phase I/II Trial of COVID-19 Vaccine
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Thermo Fisher Scientific and Q2 Solutions Partner to Deliver Clinical Trial Results Faster

Product News

Q2 Solutions has announced its partnership with Thermo Fisher Scientific to deliver clinical trial lab results economically with unprecedented speed.

READ MORE

Immune Responsive Nanoparticles for COVID-19 Vaccine Delivery

Product News

Analytik reports how the Quadram Institute has invested in a ZetaView Nanoparticle Tracking Analyser to help them develop a new approach for vaccine delivery based on engineering the natural ability of resident gut bacteria to generate nanoparticle sized Outer Membrane Vesicles.

READ MORE

Breakthrough MALDI-2 Source on timsTOF fleX and Innovations in CCS-Enabled 4D Proteomics on timsTOF

Product News

At the virtual ASMS 2020 Reboot conference, Bruker Corporation has announced a major advance in matrix-assisted laser desorption ionization (MALDI) with the launch of the world’s first commercial MALDI-2 post-ionization source.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE